Tag: Oncology
-
Ascletis Announces Positive Topline Results for Denifanstat (ASC40) in Phase III Open-Label Study
Overview of Positive Topline Results Ascletis announced positive topline results from a Phase III open-label study evaluating Denifanstat (ASC40), a once-daily oral fatty acid synthase (FASN) inhibitor. The interim findings highlight favorable safety and tolerability, alongside encouraging efficacy signals that align with the company’s previously reported data. The open-label design focused on long-term safety in…
-
Kazia Therapeutics Reports Encouraging Early Signals for Paxalisib in Late-Stage Metastatic Triple-Negative Breast Cancer
Overview of the Phase 1b Study Kazia Therapeutics (NASDAQ: KZIA) announced encouraging early clinical responses from its ongoing Phase 1b trial evaluating paxalisib in combination with pembrolizumab and chemotherapy for patients with late-stage, metastatic triple-negative breast cancer (TNBC). The update signals potential activity for paxalisib, a PI3K/AKT/mTOR pathway inhibitor, when combined with standard immuno-oncology and…
-
Trump Policies vs. New Covid Long-Haul Science: Autism, Dormant Cancer, and Brain Aging
Introduction: Policy, Science, and the evolving landscape of long Covid The Covid-19 era reshaped public health policy in ways that continue to ripple through science and medicine. As researchers uncover new facets of long Covid, autism risk signals, dormant cancer cell activity, and brain aging, questions arise about how past policy decisions align with or…
-
Financial Factors Influence Cancer Trial Enrollment in Oncology
Why finances matter more than demographics in trial enrollment A growing body of evidence suggests that financial resources play a pivotal role in whether cancer patients enroll in clinical trials. In findings highlighted by researchers and published in a prominent oncology journal, financial factors—such as lost wages, travel costs, childcare, and out-of-pocket medical expenses—can influence…
-
Financial Factors Drive Cancer Patients’ Enrollment in Clinical Trials More than Demographics
Introduction: Why Money Matters in Cancer Clinical Trials Enrollment in oncology clinical trials is a critical pathway to advancing cancer care. Recent evidence published in the Journal of the National Comprehensive Cancer Network indicates that financial resources play a larger role in whether patients enroll than traditional demographic characteristics such as age, race, or education.…
-
HanchorBio and WuXi Biologics Forge Fusion Protein Partnership
Strategic Alliance to Accelerate Next-Generation Bi- and Multi-Functional Fusion Proteins HanchorBio, Inc. and WuXi Biologics have announced a strategic partnership designed to advance a next-generation pipeline of bi- and multi-functional fusion proteins. The collaboration brings together HanchorBio’s clinical-stage expertise in immunotherapy with WuXi Biologics’ global manufacturing and development capabilities, aiming to accelerate the discovery, optimization,…
-
HanchorBio WuXi Biologics Partnership Advances Proteins
Strategic Partnership Expands Next-Generation Fusion Protein Pipeline HanchorBio, a global clinical-stage biotechnology company focused on next-generation immunotherapies, and WuXi Biologics, a leading contract development and manufacturing organization for biologics, announced a strategic collaboration to accelerate the development of next-generation bifunctional fusion proteins. The alliance aims to advance a robust pipeline targeting oncology and autoimmune diseases,…
-
HanchorBio and WuXi Biologics Forge Strategic Partnership to Accelerate Next-Gen Bi- and Multi-Functional Fusion Protein Pipeline
Strategic Partnership Aims to Accelerate Next-Generation Fusion Protein Programs HanchorBio, Inc., a global clinical-stage biotechnology company focused on next-generation immunotherapies for oncology and autoimmune diseases, and WuXi Biologics, a leading global biopharmaceutical development and manufacturing services provider, today announced a strategic partnership to advance a next-generation bi- and multi-functional fusion protein pipeline. This collaboration is…
-
The Burden of Cervical Cancer in Kenya: Understanding the Challenge and Way Forward
Overview: Cervical Cancer in Kenya Cervical cancer remains a major public health challenge in Kenya, and it is the leading cause of cancer-related deaths among women in the country. Each year, thousands of Kenyan women are diagnosed with the disease, with many cases detected at late, advanced stages when treatment is less effective. This burden…
-
Scientists Uncover Plant Secret That Could Help Fight Cancer
Nature’s Pharmacy: How Plants Are Shaping Modern Cancer Research For centuries, humans have looked to the plant kingdom for remedies to ailments big and small. Today, scientists are translating that ancient wisdom into rigorous, evidence-based medicine. A new wave of research is shedding light on a plant secret — a biochemical pathway that could bolster…